GlobalMinds Dementia extracts and analyses DNA and other biological information from blood donated to the study, such as blood-based biomarkers, and pairs this with responses to our questionnaire and data from the individual’s NHS health record.
These insights will be combined from a thousand participants. The resulting dataset will be a powerful tool for researchers to understand what influences the risks, development and severity of different forms of dementia.